Cargando...
Use of non-selective beta blockers in cirrhosis: The evidence we need before closing (or not) the window
Non selective beta blockers (NSBBs) are used in primary and secondary prophylaxis of portal hypertension-related bleeding in patients with cirrhosis. The efficacy of NSBBs treatment is predicted by hemodynamic response in term of reduction of the hepatic venous pressure gradient (HVPG) below 12 mmHg...
Gardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342901/ https://ncbi.nlm.nih.gov/pubmed/25741132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i8.2265 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|